
Alcidion Group Ltd - Strategy, SWOT and Corporate Finance Report
Description
Alcidion Group Ltd - Strategy, SWOT and Corporate Finance Report
Summary
Alcidion Group Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.
Key Highlights
Alcidion Group Ltd (Alcidion) is a health informatics company which designs, develops, and implements smart software solutions and services for healthcare organizations and hospitals. The company's product portfolio includes health informatics platforms such as Miya Precision, Patientrack, Silverlink PCS, ExtraMed, and Smartpage. Its health informatics platforms incorporates clinical decision support engine, electronic medical records (EMR), data integration, terminology support, standard-based web services, and electronic smart forms. The company has operations in Australia, the UK, and New Zealand. Alcidion is headquartered in South Yarra, Victoria, Australia.
Scope
- Detailed information on Alcidion Group Ltd required for business and competitor intelligence needs
- A study of the major internal and external factors affecting Alcidion Group Ltd in the form of a SWOT analysis
- An in-depth view of the business model of Alcidion Group Ltd including a breakdown and examination of key business segments
- Intelligence on Alcidion Group Ltd's mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about Alcidion Group Ltd, such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends
- Gain understanding of Alcidion Group Ltd and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess Alcidion Group Ltd as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers' businesses better.
- Stay up to date on Alcidion Group Ltd's business structure, strategy and prospects.
Table of Contents
42 Pages
- COMPANY OVERVIEW AND KEY FACTS
- TARGETS AND PARTNERS
- MERGERS & ACQUISITIONS
- Mergers and Acquisitions - Overview
- Mergers and Acquisitions - Deal reports
- PARTNERSHIP
- Partnership - Overview
- Partnership - Deal reports
- CAPITAL RAISING
- Capital Raising - Overview
- Capital Raising - Deal reports
- PRIVATE EQUITY & OWNERSHIP
- Private Equity and Ownership - Overview
- Private Equity and Ownership - Deal reports
- APPENDIX
- Contact Us
- About MarketLine Financial Deals Database
- Deal Definition and Methodology
- About MarketLine
- List of Tables
- Table 1: Aldeyra Therapeutics Inc M&A volume and value trend (2019-YTD2023)
- Table 2: Aldeyra Therapeutics Inc M&A activity by geography (2019-YTD2023)
- Table 3: Aldeyra Therapeutics Inc partnership volume and value trend (2019-YTD2023)
- Table 4: Aldeyra Therapeutics Inc partnership trend by key deal type (2019-YTD2023)
- Table 5: Aldeyra Therapeutics Inc capital raising volume and value trend (2019-YTD2023)
- Table 6: Aldeyra Therapeutics Inc capital raising by deal type (2019-YTD2023)
- Table 7: Aldeyra Therapeutics Inc private equity and ownership volume and value trend (2019-YTD2023)
- Table 8: Aldeyra Therapeutics Inc private equity and ownership activity by deal type (2019-YTD2023)
- List of Figures
- Figure 1: Aldeyra Therapeutics Inc M&A volume and value trend (2019-YTD2023)
- Figure 2: Aldeyra Therapeutics Inc M&A activity by geography (2019-YTD2023)
- Figure 3: Aldeyra Therapeutics Inc partnership volume and value trend (2019-YTD2023)
- Figure 4: Aldeyra Therapeutics Inc partnership trend by key deal type (2019-YTD2023)
- Figure 5: Aldeyra Therapeutics Inc capital raising volume and value trend (2019-YTD2023)
- Figure 6: Aldeyra Therapeutics Inc capital raising by deal type (2019-YTD2023)
- Figure 7: Aldeyra Therapeutics Inc private equity and ownership volume and value trend (2019-YTD2023)
- Figure 8: Aldeyra Therapeutics Inc private equity and ownership by deal type (2019-YTD2023)
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.